This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Schuckit, M. A. Educating Yourself About Alcohol and Drugs. New York: Plenum Publishing Co., 1998.
American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders (4th ed., text revision, DSM-IV TR). Washington, DC: American Psychiatric Press, 2000.
Fillmore, K. M., Kerr, W. C., & Bostrom, A. Changes in drinking status, serious illness and mortality. Journal of Studies on Alcohol 64:278–285, 2003.
Romero-Gomez, M., Grande, L., Nogales, M. C., Fernandez, M., Chavez, M., & Castro, M. Chronic alcohol use enhances the hepatitis C virus load in the liver. Alcohol Research 7:66, 2002.
Samet, J. H., Horton, N. J., Traphagen, E. T., Lyon, S. M., & Freedberg, K. A. Alcohol consumption and HIV disease progression: Are they related? Alcoholism: Clinical and Experimental Research 27:862–867, 2003.
Chang, G., & Kosten, T. R. Detoxification. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 579–587.
Ma, O. J., & Kline, D. M. (Eds.). Emergency Medicine Manual (6th ed.). New York: McGraw-Hill Publishers, 2004.
Gutstein, H. B., & Akil, H. Opioid analgesics. In J. G. Hardman, L. E. Limbird, & A. G. Goodman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 569–620.
Charney, D. S., Mihic, J., & Harris, R. A. Hypnotics and sedatives. In J. G. Hardman, L. E. Limbird, & A. G. Goodman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 399–427.
Mausner, K. L. Sedatives and hypnotics. In O. J. Ma & D. M. Cline (Eds.), Emergency Medicine Manual (6th ed.). New York: McGraw-Hill Publishers, 2004, pp. 489–493.
D’Souza, D. C., Perry, E., MacDougal, L., Ammerman, Y., Cooper, T., Wu, Y.-T, Braley, G., Gueorguieva, R., & Krystal, J. H. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology 29:1158–1172, 2004.
Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry 158:1206–1214, 2001.
Curran, H. V., & Monaghan, L. In and out of the K-hole: A comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 96:749–760, 2001.
Preuss, U.W., Schuckit, M. A., Smith, T. L., Danko, G. P., Bucholz, K. K., Hesselbrock, M. N., Hesselbrock, V., & Kramer, J. R. Predictors and correlates of suicide attempts over 5 years in 1,237 alcohol-dependent men and women. American Journal of Psychiatry 160:56–63, 2003.
Preuss, U.W., Schuckit, M. A., Smith, T. L., Danko, G. P., Dasher, A. C., Hesselbrock, M. N., Hesselbrock, V. M., & Nurnberger, J. I., Jr. A comparison of alcohol-induced and independent depression in alcoholics with histories of suicide attempts. Journal of Studies on Alcohol 63:498–502, 2002.
Brook, D. W., Brook, J. S., Zhang, E., Cohen, P., & Whiteman, M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Archives of General Psychiatry 59:1039–1044, 2002.
Gonzalez, G., Feingold, A., Oliveto, A., Gonsai, K., & Kosten, T. R. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. The American Journal of Drug and Alcohol Abuse 29:497–514, 2003.
Goodwin, R. D., Fergusson, D. M., & Horwood, L. J. Association between anxiety disorders and substance use disorders among young persons: Results of a 21-year longitudinal study. Journal of Psychiatric Research 38:295–304, 2004.
Hernandez-Avila, C. A., Modesto-Lowe, V., Feinn, R., & Kranzler, H. R. Nefazodone treatment of comorbid alcohol dependence and major depression. Alcoholism: Clinical and Experimental Research 28:433–440, 2004.
Kelly, J. F., McKellar, J. D., & Moos, R. Major depression in patients with substance use disorders: Relationship to 12-step self-help involvement and substance use outcomes. Addiction 98:499–508, 2003.
Schuckit, M. A., Tipp, J. E., Bergman, M., Reich, W., Hesselbrock, V. M., & Smith, T. L. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. American Journal of Psychiatry 154:948–957, 1997.
Mason, B. J., Kocsis, J. H., Ritvo, E. C., & Cutler, R. B. A double-blind placebo-controlled trial of desipramine in primary alcoholics stratified on the presence or absence of major depression. Journal of the American Medical Association 275:1–7, 1996.
Cornelius, J. R., Salloum, I. M., Ehler, J. G., Jarrett, P. J., Cornelius, M. D., Perel, J. M., Thase, M. E., & Black, A. Fluoxetine in depressed alcoholics. Archives of General Psychiatry 54:700–705, 1997.
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
(2006). Emergency Problems: A Quick Overview. In: Drug and Alcohol Abuse. Springer, Boston, MA. https://doi.org/10.1007/0-387-25733-0_13
Download citation
DOI: https://doi.org/10.1007/0-387-25733-0_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25732-7
Online ISBN: 978-0-387-25733-4
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)